Crispr Therapeutics AG CRSP
$52.19
▼ -0.86% 24H
About
CRISPR Therapeutics AG is a Swiss biotechnology company focused on gene editing-based medicines for serious diseases. The company develops therapies using its proprietary CRISPR/Cas9 platform, which enables precise changes to DNA and supports a portfolio of programs across hemoglobin disorders, oncology, regenerative m…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountrySwitzerland
Employees393
TickerCRSP
Statistics
Market Cap$5.03B
Revenue (TTM)$3.5M
Net Income-$581.6M
Net Margin-16569.8%
EPS$-6.47
P/E-7.77
P/S1205.67
P/B2.67
EV/EBITDA-5.86
ROE-31.2%
Dividend Yield—
Price$52.19
Data: Twelve Data · Revenue = mcap / P/S